0
The TCR-based therapy market is projected to grow at an annualized rate of 51%, claims Roots Analysis www.rootsanalysis.comban site
Given the recent approval of a TCR-based therapy, industry stakeholders have initiated several R&D efforts focused on evaluating the potential of such therapy candidates against various disease indications
category news
posted by berry_cristan 2 years ago
0 comments
flag/unflag
delete
delete and ban this url
Comments (0)
You need to be logged in to write comments!
This story has no comments.